文献速递慢性肾脏病血液净化与透析

主持人观点:预测模型——精准肾脏病学的序幕

Moderator's view: Predictive models: a prelude to precision nephrology.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本文讨论了预测模型在肾脏病学中的价值:预后不仅取决于诊断,治疗决策也非仅基于诊断,在加拿大应用经验证的风险方程使新转诊减少35%。但现有预测模型研究常忽略竞争事件与测量误差,缺乏校准分析和外部验证。呼吁肾脏病学界应用最佳验证风险评分并在不同临床情境和地区进一步测试。

要点

  • 在加拿大应用经验证的肾衰竭风险方程使新转诊减少35%。
  • 现有肾脏病预测模型研究常忽略竞争事件和测量误差,缺乏校准与外部验证。
  • 建议开始应用最佳验证风险评分并在不同临床情境和地区测试其效用。

核心结论

  • 预测模型有助于在个体层面预后并优化治疗决策,但现有肾脏病预测模型研究仍不理想。

研究设计与样本

  • 本文为Nephrol Dial Transplant发表的主持人观点文章,非系统研究。

主要发现

  • 在加拿大应用经验证的肾衰竭风险方程使新转诊减少35%。
  • 基于临床档案可提取的简单临床数据已开发出预测终末期肾病患者全因和心血管死亡的模型。

关键数值与推荐

  • 加拿大经验证肾衰竭风险方程应用后新转诊减少35%。

临床怎么用

  • 肾脏病学界可开始应用最佳验证风险评分,并在不同临床情境和地区测试其效用。

局限性

  • 现有预测模型研究常忽略竞争事件和测量误差,缺乏校准分析和外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Appropriate diagnosis is fundamental in medicine because it sets the basis for the prediction of disease outcome at the single patient level (prognosis) and decisions regarding the most appropriate therapy. However, given the large series of social, clinical and biological factors that determine the likelihood of an individual's future outcome, prognosis only partly depends on diagnosis and aetiology and treatment is not decided solely on the basis of the underlying diagnosis. This issue is crucial in multifactorial diseases like atherosclerosis, where the use of statins has now shifted from 'treating hypercholesterolaemia' to 'treating the risk of adverse cardiovascular events'. Approaches that take due account of prognosis limit the lingering risk of over-diagnosis and maximize the value of prognostic information in the clinical decision process. In the nephrology realm, the application of a well-validated risk equation for kidney failure in Canada led to a 35% reduction in new referrals. Prognostic models based on simple clinical data extractable from clinical files have recently been developed to predict all-cause and cardiovascular mortality in end-stage kidney disease patients. However, research on predictive models in renal diseases remains suboptimal and non-accounting for competing events and measurement errors, and a lack of calibration analyses and external validation are common fallacies in currently available studies. More focus on this blossoming research area is desirable. The nephrology community may now start to apply the best validated risk scores and further test their potential usefulness in chronic kidney disease patients in diverse clinical situations and geographical areas.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Zoccali C. Moderator's view: Predictive models: a prelude to precision nephrology. Nephrol Dial Transplant. 2017. PMID: 28499030. doi:10.1093/ndt/gfx077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。